Murray B. Urowitz mostly deals with Internal medicine, Lupus erythematosus, Systemic lupus erythematosus, Immunology and Connective tissue disease. His work investigates the relationship between Internal medicine and topics such as Surgery that intersect with problems in Coronary artery disease. His Lupus erythematosus research is multidisciplinary, incorporating perspectives in Epidemiology, Survival rate, Disease, Univariate analysis and Risk factor.
Murray B. Urowitz has researched Systemic lupus erythematosus in several fields, including Predictive value of tests, Case-control study, Confidence interval, Prednisone and Prospective cohort study. His research in Immunology intersects with topics in Lupus nephritis, Incidence and Oncology. His research integrates issues of Systemic disease and Quality of life in his study of Connective tissue disease.
Murray B. Urowitz mainly investigates Internal medicine, Systemic lupus erythematosus, Lupus erythematosus, Immunology and Cohort. His Internal medicine study combines topics in areas such as Gastroenterology and Surgery. The concepts of his Systemic lupus erythematosus study are interwoven with issues in Disease activity, Lupus nephritis, Physical therapy and Coronary artery disease.
Murray B. Urowitz interconnects Proteinuria, Nephritis, Kidney disease and Renal function in the investigation of issues within Lupus nephritis. The study incorporates disciplines such as Epidemiology, Young adult, Systemic disease, Prospective cohort study and Severity of illness in addition to Lupus erythematosus. His Incidence research extends to the thematically linked field of Cohort.
His primary scientific interests are in Internal medicine, Systemic lupus erythematosus, Cohort, Rheumatology and Lupus nephritis. His Internal medicine study often links to related topics such as Lupus erythematosus. Murray B. Urowitz focuses mostly in the field of Systemic lupus erythematosus, narrowing it down to matters related to Incidence and, in some cases, Mean age and Disease duration.
His Cohort research includes themes of Belimumab, Epidemiology, Risk factor and Propensity score matching. His Rheumatology research includes elements of Odds ratio and Rheumatism. His Disease study combines topics from a wide range of disciplines, such as Immunology and Confounding.
Murray B. Urowitz mainly focuses on Internal medicine, Systemic lupus erythematosus, Lupus erythematosus, Cohort and Rheumatology. The various areas that Murray B. Urowitz examines in his Internal medicine study include Anti-nuclear antibody and Gastroenterology. His work carried out in the field of Systemic lupus erythematosus brings together such families of science as Age specific, Malignancy, All cause mortality and Standardized mortality ratio.
Murray B. Urowitz has included themes like Young adult, Predictive value of tests, Severity of illness and Serology in his Lupus erythematosus study. His Cohort research incorporates elements of SLICC Criteria, Acr criteria and Medical diagnosis. His biological study spans a wide range of topics, including Lupus nephritis and Human leukocyte antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
C. Bombardier;D. D. Gladman;M. B. Urowitz;D. Caron.
Arthritis & Rheumatism (1992)
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon.
Arthritis & Rheumatism (2012)
Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman;Dominique Ibañez;Murray B Urowitz.
The Journal of Rheumatology (2002)
The bimodal mortality pattern of systemic lupus erythematosus
Murray B. Urowitz;Arthur A.M. Bookman;Barry E. Koehler;Duncan A. Gordon.
The American Journal of Medicine (1976)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks.
Arthritis & Rheumatism (2019)
Mortality in systemic lupus erythematosus.
S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi.
Arthritis & Rheumatism (2006)
Systemic lupus erythematosus.
Arvind Kaul;Caroline Gordon;Mary K Crow;Zahi Touma.
Nature Reviews Disease Primers (2016)
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.
Dafna D. Gladman;Murray B. Urowitz;Charles H. Goldsmith;Paul Fortin.
Arthritis & Rheumatism (1997)
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Mahmoud Abu-Shakra;M. B. Urowitz;D. D. Gladman;J. Gough.
The Journal of Rheumatology (1995)
Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study
Ian N. Bruce;Murray B. Urowitz;Dafna D. Gladman;Dominique Ibañez.
Arthritis & Rheumatism (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Toronto Western Hospital
Université Laval
University of Calgary
Northwestern University
University of Manchester
University of Birmingham
University of California, Los Angeles
University College London
Johns Hopkins University School of Medicine
Hanyang University
Columbia University
University of Liège
Duke University
Nanjing University
Osaka Metropolitan University
Centre national de la recherche scientifique, CNRS
British Antarctic Survey
University of Toronto
University of Massachusetts Medical School
Desert Research Institute
University College London
University of Montreal
University of Padua
International Agency For Research On Cancer
Oregon Health & Science University
Monash University